10/16/2026
The FDA accepts Anaphylm's resubmitted application, setting a March 2027 decision date for the needle-free epinephrine treatment.
Anjo.ai
- Home
- United States
- New York, NY
- Anjo.ai
For the safety and quality of life of those who are at risk of life-threatening allergic reactions (anaphylaxis).
Address
New York, NY
Website
Alerts
Be the first to know and let us send you an email when Anjo.ai posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
